| Title: | EpiSNPdb: A Comprehensive Database of Genetic Epistasis Across Multiple Cancer Types |
| Journal: | Current Issues in Molecular Biology |
| Published: | 24 Jul 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42651752/ |
| DOI: | https://doi.org/10.3390/cimb48080753 |
Publication 21365
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Increasing evidence shows that epistasis, defined as interactive effects between genetic loci, may contribute to the missing heritability of cancer. However, systematic genome-wide epistasis identification in cancer remains challenging. Here, by leveraging genotype and clinical data from 380,983 samples in the UK Biobank, we identified 202,032 candidate epistatic single nucleotide polymorphism (epiSNP) pairs associated with cancer risk across 16 cancer types. Notably, multivariable Cox regression identified 123 epiSNP pairs with significant interaction effects on overall survival, suggesting that interaction-level genetic signals can provide prognostic information beyond individual SNP effects. Through functional analysis of the 202,032 candidate epiSNP pairs, we identified 7152 pairs supported by gene co-expression data and 12,326 pairs with protein-protein interaction (PPI) evidence. By mapping epiSNP pairs to corresponding gene pairs and then linking these gene pairs to drug-target databases, we identified 1040 epistatic gene pairs with FDA-approved drug-target records. Additionally, through KM survival analysis of the candidate epiSNP pairs, we detected 7068 pairs significantly associated with patient overall survival. Finally, we constructed an open-access database, EpiSNPdb, to facilitate cancer epistasis research.</p>
8 Authors
- Xiaohong Wu
- Jianye Yang
- Wen Cao
- Jiaxin He
- Congcong Min
- Xiaohui Niu
- Yuan Quan
- Jing Gong
1 Application
| Application ID | Title |
|---|---|
| 97563 | Facilitating combinatorial drug discovery by targeting epistatic disease genes. |
Enabling scientific discoveries that improve human health